For more information on Pharma and Biotech or other ways AWS can help your organization visit us at: aws.amazon.com/health/biotech-pharma
© 2020, Amazon Web Services, Inc. or its Affiliates. All rights reserved.
Building Secure & Scalable Digital
Therapeutics on AWS
Digital therapeutics (DTx) are evidence-based therapy interventions driven by high quality software and technology
to help patients prevent, manage, or treat a broad range of conditions. DTx encompasses several subcategories:
• Smart pills and connected inhalers to support pharmacological interventions by improving compliance and
generating insights into patient behavior
• Companion apps that leverage mobile technology to enhance the patient experience.
• Standalone DTx to improve health outcomes independently of drug regimens.
The Digital Therapeutics program at AWS is geared towards enabling
life science organizations to develop, build, deploy, and optimize DTx
programs using cloud-based technology. Below is a common HIPAA-eligible
architecture pattern that AWS customers are using to develop DTx programs,
harness data to improve patient engagement, and use analytics and machine
learning to help predict patient health events.
Amazon Web Services (AWS) offers HIPAA-eligible capabilities that benefit
life science organizations through:
$1B 40%
US investment
into DTx in 2018
1
annual growth
of DTx
1
1
https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/the-promise-of-digital-therapeutics
Scalability
Build fast, low-latency
patient applications
Personalization
Incorporate patient
personalization for
improved engagement
and usage
Data Security
Comply with industry
regulations and keep
patient data secure
New data Insights
Use analytics and
machine learning on
diverse data sources